|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
27 Number 4
10 February 2025
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
27, Year 2025 >
Number 4, 10 February
|
|
|
|
|
|
Liu J, Wang Y, Song Z, Zhang Y.
Nanoengineered
immune check point inhibitors delivery for targeted brain cancer
treatment: Current status and future perspectives.
Biochem
Pharmacol. 2025 Feb 1;233:116789. doi:
10.1016/j.bcp.2025.116789. PMID:
39900203. Review˰ ˍ
|
|
|
|
Shah S, Nag A, Lucke-Wold B.
Association
of tumor treating fields (TTFields) therapy with overall survival
in newly diagnosed glioblastoma.
Clin
Transl Oncol. 2025 Feb 1. doi:
10.1007/s12094-025-03849-6. PMID:
39893330. Review˰ ˍ
|
|
|
|
Shahedi F, Naseri S, Momennezhad M, Zare H.
MR
Imaging Techniques for Microenvironment Mapping of the Glioma
Tumors: A Systematic Review.
Acad
Radiol. 2025 Feb 1:S1076-6332(25)00066-2. doi:
10.1016/j.acra.2025.01.024. PMID:
39894708. Review˰ ˍ
|
|
|
|
Cong G, Zhu X, Chen XR, Chen H, Chong W.
Mechanisms
and therapeutic potential of the hedgehog signaling pathway in
cancer.
Cell
Death Discov. 2025 Feb 3;11(1):40. doi:
10.1038/s41420-025-02327-w. PMID:
39900571. Review. ˍ
|
|
|
|
*Fares J, Petrosyan E, Dmello C, Lukas RV, Stupp R, Lesniak MS.
Rethinking metastatic brain cancer as
a CNS disease.
Lancet Oncol. 2025 Feb
3;26(2):e111-e121. doi:
10.1016/S1470-2045(24)00430-3. PMID:
39914421. Perspective˰
ˍ
|
|
|
|
Chithra P, Bhatia D, Solanki R.
Advanced
nanomicelles for targeted glioblastoma multiforme therapy.
Biomater
Adv. 2025 Feb 4;170:214221. doi:
10.1016/j.bioadv.2025.214221. PMID:
39922136. Review˰ ˍ
|
|
|
|
D'Antonio F, Spinello Z, Bargiacchi L, Splendiani E, Rossi S,
Masuelli L, Mastronuzzi A, Locatelli F, Ferretti E, Catanzaro
G.
Circulating microRNAs: A remarkable
opportunity as non-invasive biomarkers from adult to pediatric
brain tumor patients.
Crit
Rev Oncol Hematol. 2025 Feb 4;208:104650. doi:
10.1016/j.critrevonc.2025.104650. PMID:
39914569. Review˰ ˍ
|
|
|
|
Hajikarimloo B, Tos SM, Alvani MS, Kooshki A, Hasanzade A, Zare
AH, Zare AH, Najari D, Habibi MA.
Efficacy
and safety of dabrafenib plus trametinib in pediatric versus adult
gliomas: a systematic review and meta-analysis.
Childs
Nerv Syst. 2025 Feb 4;41(1):104. doi:
10.1007/s00381-025-06760-1. PMID:
39904910. Review; Meta-analysis˰
ˍ
|
|
|
|
Shadab A, Farokhi S, Fakouri A, Mohagheghzadeh N, Noroozi A,
Razavi ZS, Karimi Rouzbahani A, Zalpoor H, Mahjoor M.
Hydrogel-based nanoparticles:
revolutionizing brain tumor treatment and paving the way for
future innovations.
Eur
J Med Res. 2025 Feb 4;30(1):71. doi:
10.1186/s40001-025-02310-2. PMID:
39905470. Review. ˍ
|
|
|
|
Breen WG, Palmer JD, Johnson DR, Kim MM.
The
Role of PET/CT in Radiation Oncology for Central Nervous System
Tumors.
PET
Clin. 2025 Feb 5:S1556-8598(25)00005-7. doi:
10.1016/j.cpet.2025.01.005. PMID:
39915188. Review˰ ˍ
|
|
|
|
Liu Y, Wu H, Liang G.
Combined
Strategies for Nanodrugs Noninvasively Overcoming the Blood-Brain
Barrier and Actively Targeting Glioma Lesions.
Biomater
Res. 2025 Feb 5;29:0133. doi:
10.34133/bmr.0133. PMID:
39911305. Review. ˍ
|
|
|
|
Gao Y, Zhang M, Wang G, Lai W, Liao S, Chen Y, Ning Q, Tang S.
Metabolic cross-talk between
glioblastoma and glioblastoma-associated microglia/macrophages:
From basic insights to therapeutic strategies.
Crit
Rev Oncol Hematol. 2025 Feb 6;208:104649. doi:
10.1016/j.critrevonc.2025.104649. PMID:
39922398. Review˰ ˍ
|
|
|
|
Mi Y, Jiang P, Luan J, Feng L, Zhang D, Gao X.
Peptide-based
therapeutic strategies for glioma: Current state and prospects.
Peptides.
2025 Feb 6;185:171354. doi:
10.1016/j.peptides.2025.171354. PMID:
39922284. Review˰ ˍ
|
|
|
|
Cai T.
Hyperbaric oxygen therapy as an
adjunt treatment for glioma and brain metastasis: a literature
review.
Med
Gas Res. 2025 Feb 7. doi:
10.4103/mgr.MEDGASRES-D-24-00096. PMID:
39923138. Review. ˍ
|
|
|
|
Habibi MA, Rashidi F, Gharedaghi H, Fathi Tavani S, Farzalizadeh
H, Shahir Eftekhar M, Bahri A, Mohammadzadeh I, Hajikarimloo B.
Are EGFR monoclonal antibodies
associated with clinical benefits in patients with glioma: a
systematic review, meta-analysis, and specific analysis on
glioblastoma and diffuse intrinsic pontine glioma.
Neurosurg
Rev. 2025 Feb 8;48(1):226. doi:
10.1007/s10143-025-03335-1. PMID:
39920453. Review; Meta-analysis˰
ˍ
|
|
|
|
Liang Z, Zhao S, Liu Y, Cheng C.
The
promise of mitochondria in the treatment of glioblastoma: a brief
review.
Discov
Oncol. 2025 Feb 9;16(1):142. doi:
10.1007/s12672-025-01891-y. PMID:
39924629. Review. ˍ
|
|
|
|
Broggi G, Salzano S, Mazzucchelli M, Rosano GN, Magro G,
Caltabiano R, Barresi V.
Cerebellar
liponeurocytoma: An updated comprehensive review of
clinicopathologic,
immunohistochemical, and molecular features of an unusual but
distinct tumor.
Clin
Neuropathol. 2025 Feb 10. doi:
10.5414/NP301660. PMID:
39928112. Review˰
ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|